Astrotech Corporation (ASTC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 1 | 1 | 2 | 1 | 1 | - |
| Operating profit | $m | -15 | -14 | ||||||
| Net profit | $m | -8 | -8 | -8 | -10 | -12 | -14 | -14 | - |
| EPS reported | $ | -8.32 | -8.42 | ||||||
| Operating cashflow per share | $ | -7.78 | -8.07 | ||||||
| Capex per share | $ | 0.50 | 0.72 | ||||||
| FCF per share | $ | -8.28 | -8.79 | ||||||
| Free cash flow | $m | -14 | -14 | ||||||
| Net debt | $m | -18 | -11 | ||||||
| Book value equity | $m | 22 | 16 | ||||||
| Book value per share | $ | 13.27 | 9.65 | ||||||
| Number of shares | m | 1.67 | 1.68 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.44 | 0.60 | ||||||
| P/S LTM | x | 9.17 | 9.55 | ||||||
| P/FCF LTM | x | -0.70 | -0.67 | ||||||
| EV/EBITDA LTM | x | -0.73 | -0.72 | ||||||
| EV/Sales LTM | x | 8.77 | 14.39 | ||||||
| Earnings Yield LTM | % | -1.44% | -1.14% | ||||||
| FCF Yield | % | -143.24% | -148.92% | ||||||
| Quality | |||||||||
| ROE | % | -62.67% | -81.85% | ||||||
| ROIC | % | -59.07% | -94.49% | ||||||
| Operating margin | % | -14.05% | -13.70% | ||||||
| Gross margin | % | -64.92% | -88.10% | ||||||
| FCF/Sales | % | -1314.1% | -1461.4% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -36.96% | -39.42% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -5.15 | -6.22 | ||||||
| Net Debt/EBITDA | x | 0.03 | 0.02 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | 0.00% | +1.86% | ||||||
| Net debt/Equity | x | -0.82 | -0.70 | ||||||
| Gross debt/equity | x | 0.12 | 0.14 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Astrotech Corporation is an international company focused on developing and bringing to market scientific and technological advancements. Its operations are structured into three distinct segments: Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). ATI is responsible for holding the intellectual property rights to and licensing its proprietary AMS Technology, which serves as its foundational mass spectrometry platform. The 1st Detect division manufactures sophisticated trace detectors for identifying explosives and narcotics. Its key offering, the TRACER 1000, is an advanced mass spectrometer designed to supersede existing explosives detection equipment in high-security environments such as airports, cargo facilities, and border crossings. AgLAB's focus includes the development of the AgLAB-1000, a mass spectrometer tailored for applications within the hemp and cannabis sectors. Additionally, this segment is creating the BreathTest-1000, an analytical tool intended for screening volatile organic compound metabolites in breath samples. Originally established in 1984 under the name SPACEHAB, Inc., the company officially rebranded as Astrotech Corporation in 2009. Its corporate headquarters are situated in Austin, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Astrotech Corporation is an international company focused on developing and bringing to market scientific and technological advancements. Its operations are structured into three distinct segments: Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). ATI is responsible for holding the intellectual property rights to and licensing its proprietary AMS Technology, which serves as its foundational mass spectrometry platform. The 1st Detect division manufactures sophisticated trace detectors for identifying explosives and narcotics. Its key offering, the TRACER 1000, is an advanced mass spectrometer designed to supersede existing explosives detection equipment in high-security environments such as airports, cargo facilities, and border crossings. AgLAB's focus includes the development of the AgLAB-1000, a mass spectrometer tailored for applications within the hemp and cannabis sectors. Additionally, this segment is creating the BreathTest-1000, an analytical tool intended for screening volatile organic compound metabolites in breath samples. Originally established in 1984 under the name SPACEHAB, Inc., the company officially rebranded as Astrotech Corporation in 2009. Its corporate headquarters are situated in Austin, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free